- 2024.02.21Press Release
EME and ONO Announce Collaboration Agreement on Creating Novel VHH antibody drug discovery
- 2023.07.28Press Release
EME entered into a comprehensive collaboration agreement with Kao for Multiple Infectious Diseases with Utilizing PharmaLogical™ VHH.
- 2023.02.07Press Release
EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical® VHH to address an unmet medical need in Obstetrics and Gynecology
- 2022.03.03Press Release
EME PUBLISHES NOVEL HUMANIZED SYNTHETIC VHH LIBRARY “PharmaLogical® Library” FOR THERAPEUTIC ON ANTIBODIES JORNAL.
- 2022.01.17Press Release
Successful Treatment for Coronavirus Disease 2019 in Hamster Models: A Significant Advancement for Clinical Use of VHH Antibodies Administered Nasally
- 2021.10.26Press Release
EME Announces Research Agreement with Kyowa Kirin on VHH Antibody
- 2021.10.12Press Release
EME Announces Collaboration Agreement on Development of VHH Antibody
- 2021.09.28Press Release
EME Announces Collaboration Agreement with JCR on Drug Discovery and Development for VHHs
- 2020.12.23Press Release
Series A financing of 570 million yen procured by Epsilon Molecular Engineering: A next-generation medium sized molecular biotechnology-based drug discovery firm
